Dr. Chang Yeol Lee is a Senior Researcher at the Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB). He received his Ph.D. in Chemical and Biomolecular Engineering from KAIST. His research centers on molecular diagnostics, nucleic acid engineering, CRISPR-based biosensing, and the development of portable, integrated diagnostic systems for infectious diseases and cancers. He has authored over 45 peer-reviewed publications, including papers in Nature Communications, Science Translational Medicine, Accounts of Chemical Research, Advanced Science, and Biosensors and Bioelectronics, with multiple corresponding- and first-author contributions. His recent work highlights the integration of CRISPR diagnostics with digital signal processing, isothermal amplification, and miniaturized detection devices.